Lv5
1090 积分 2023-03-09 加入
IRAK4 Is Overexpressed in Hidradenitis Suppurativa Skin and Correlates with Inflammatory Biomarkers
1个月前
已完结
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
1个月前
已完结
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of KT-474, a Novel Selective Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degrader, in Healthy Adults
1个月前
已关闭
Serologic Response to Varicella-Zoster Membrane Antigens Measured by Indirect Immunofluorescence
1个月前
已关闭
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
1个月前
已完结
518. Model-informed Dose Selection of Dual Toll-like Receptor 7/8 Inhibitor Enpatoran (M5049) for the Treatment of COVID-19 Pneumonia
3个月前
已完结
皖公网安备34019202002308
